Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DUS1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NUFIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GYG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MLX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF275 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MGAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFXL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RMDN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYEF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIAPH3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIST1H2AJ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACLY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CXADR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIST1H2BH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP9A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on